Skip to main content

Advertisement

Table 1 MIC in µg/ml of synthesized indole hybridized diazenyl derivatives

From: Indole hybridized diazenyl derivatives: synthesis, antimicrobial activity, cytotoxicity evaluation and docking studies

Compd. E. coli S. aureus S. enterica B. subtilis K. pneumonia A. niger A. fumigatus
MIC (µg/ml)
 DS-1 15.62 62.5 62.5 62.5 3.90 125 62.5
 DS-2 15.62 62.5 15.62 31.25 31.25 62.5 15.62
 DS-3 3.90 62.5 31.25 31.25 1.95 62.5 15.62
 DS-5 1.95 125 31.25 62.5 3.90 62.5 125
 DS-6 1.95 31.25 31.25 31.25 7.81 62.5 31.25
 DS-7 7.81 62.5 31.25 125 3.90 62.5 62.5
 DS-10 1.95 62.5 31.25 62.5 3.90 62.5 125
 DS-11 3.90 31.25 62.5 31.25 15.62 125 62.5
 DS-13 7.81 62.5 62.5 62.5 3.90 62.5 31.25
 DS-14 3.90 62.5 1.95 31.25 1.95 62.5 31.25
 DS-15 15.62 125 31.25 31.25 3.90 125 62.5
 DS-16 15.62 62.5 62.5 31.25 7.81 62.5 31.25
 DS-17 3.90 62.5 62.5 125 7.81 62.5 31.25
 DS-19 7.81 31.25 62.5 31.25 15.26 31.25 31.25
 DS-20 1.95 125 15.62 125 3.90 62.5 62.5
 DS-21 3.90 62.5 31.25 31.25 3.90 125 125
 CFT 1.95 15.62 15.62 15.62 1.95
 CPR 3.90 1.95 15.62 7.81 7.81
 FLU 31.25 7.81
  1. CFT cefotaxime, CPR ciprofloxacin, FLU fluconazole